Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chondroitin sulfate + glucosamine hydrochloride versus celecoxib in knee osteoarthritis
2010-024010-61Phase 4Completed
- Sponsor
- Bioiberica
- Start
- Jul 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of chondroitin sulfate, glucosamine sulphate and celecoxib in knee osteoarthritis (OA) (2 arms), sponsored by Bioiberica. Primary endpoint: Change from baseline in WOMAC pain subscale at 6 months. Started Jul 2011; status: completed.
02
Drugs
chondroitin sulfateglucosamine sulphatecelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2010-024010-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024010-61.